SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Share your aches,pains,experiences,joys and cures. -- Ignore unavailable to you. Want to Upgrade?

To: Cogito who wrote (728)5/9/2007 6:50:41 PM
From: MulhollandDrive  Respond to of 1564
 
But seriously, the federal government could easily finance a study. If it is effective, such a treatment might save Medicare billions of dollars.

exactly....

as you say, calling it a cure is totally premature, but it demonstrates the problem big pharma has when it comes to non-patentable drugs

one of the *rare* instances where the profit motive works against the benefit of discovery

so why not a bill gates or steve jobs or warren buffett step up to the plate to fund the research.....if such a 'cure' were to be developed, they would go down in history as the world's greatest philanthropists whose fortunes alleviated the suffering of untold millions



To: Cogito who wrote (728)5/9/2007 8:10:12 PM
From: Patricia Trinchero  Read Replies (1) | Respond to of 1564
 
Drug companies shell out hundreds of millions all the time for trails. A Phase III trial alone costs well into the hundreds of millions. Efficacy and safety trials are done in people first and only after extensive research is completed.

Let them show us the early preclinical data that is peer reviewed.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News